CBL vs NYR

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

CBL

CTRLBIONIC FPO [CBL]

52MEDIUM

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

Score Breakdown

CBL NYR
Technical
45
56
Catalyst
50
53
Sentiment
50
50
Fundamental
55
38
Momentum
75
71
Risk Gate
47
42

Key Metrics

CBL Metric NYR
$21.4MMarket Cap$134.7M
198KAvg Volume (20d)516K
N/AShort InterestN/A
$0.08652-Week High$1.435
$0.02652-Week Low$0.091
-10.3%Daily Change-3.2%
$0.052Entry Price$0.537
-91.6%ROE-71.0%
-107.0%Profit Margin-234.3%

Active Signals

CBL Signals

●RSI drifting toward oversold territory — worth watching
●MACD crossed bearish — momentum is fading
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Took a hit — down 13.3% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Low cash runway (3 quarters) - dilution risk

NYR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Very high P/S ratio (56.6x)
●Piotroski F-Score weak (3/9, low-confidence approx)
●CANSLIM S: Tight float (44%)

Ask Scout AI to compare CBL and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CBL Full Analysis → NYR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).